F.D.A. Panel Unanimously Recommends Johnson & Johnson Booster Shots
By BY SHARON LAFRANIERE, NOAH WEILAND AND CARL ZIMMER
Health
https://ift.tt/3FQF4EG
But many panel members said J. & J. recipients might also benefit from the option of a Pfizer-BioNTech or Moderna booster, an action that an F.D.A. official said was possible.
New York Times
Vaccination and Immunization, Coronavirus (2019-nCoV), Regulation and Deregulation of Industry
October 16, 2021 at 12:02AM